Originally published In Press as doi:10.1074/jbc.M200263200 on March 15, 2002
J. Biol. Chem., Vol. 277, Issue 22, 20059-20069, May 31, 2002
The Crystal Structure of Prokaryotic
Phospholipase A2*
Yasuyuki
Matoba
,
Yukiteru
Katsube§, and
Masanori
Sugiyama
¶
From the
Institute of Pharmaceutical Sciences,
Faculty of Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku,
Hiroshima 734-8551 and the § Institute of X-ray Research,
Rigaku Co., 3-9-12, Matsubara-cho, Akishima,
Tokyo 196-0003, Japan
Received for publication, January 10, 2002, and in revised form, February 27, 2002
 |
ABSTRACT |
In this study, the x-ray crystal structures of
the calcium-free and calcium-bound forms of phospholipase
A2 (PLA2), produced extracellularly by
Streptomyces violaceoruber, were determined by
using the multiple isomorphous replacement and molecular replacement methods, respectively. The former and latter structures were refined to
an R-factor of 18.8% at a 1.4-Å resolution and an
R-factor of 15.0% at a 1.6-Å resolution, respectively.
The overall structure of the prokaryotic PLA2 exhibits a
novel folding topology that demonstrates that it is completely distinct
from those of eukaryotic PLA2s, which have been already
determined by x-ray and NMR analyses. Furthermore, the coordination
geometry of the calcium(II) ion apparently deviated from that of
eukaryotic PLA2s. Regardless of the evolutionary
divergence, the catalytic mechanism including the calcium(II) ion on
secreted PLA2 seems to be conserved between prokaryotic and
eukaryotic cells. Demonstrating that the overall structure determined
by x-ray analysis is almost the same as that determined by NMR
analysis is useful to discuss the catalytic mechanism at the molecular
level of the bacterial PLA2.
 |
INTRODUCTION |
Phospholipase A2
(PLA21; EC
3.1.1.4) is an enzyme that liberates fatty acid together with
lysophospholipid by hydrolyzing the 2-ester bond of
1,2-diacyl-3-sn-phosphoglycerides. The enzyme, which has
been found only by eukaryotic cells, can be broadly divided into two
categories, namely secreted and cytosolic types (1). In recent years, a
proposal for classification has been made after many types of
PLA2 in each category were found. According to this
classification, secreted PLA2s are grouped into classes I,
II, III, V, IX, X, XI, and XII (2, 3). Classes IV, VI, VII, and VIII
are included in cytosolic PLA2 (2). We have
discovered a bacterial PLA2 of the secreted type and
propose to establish a new class, which is described in the
accompanying paper (41).
All secreted PLA2s require calcium(II) ion for the
expression of enzymatic activity. Interestingly, the kinetic study of
the S. violaceoruber PLA2 with
respect to the dissociation constant for calcium(II) ion suggested that
the binding affinity of the ion for the prokaryotic PLA2 is
1 order of magnitude lower than that for the eukaryotic enzyme
(41). In addition, the bacterial PLA2 prefers
phosphatidylcholine as a substrate to phosphatidylethanolamine. The
primary structure of the prokaryotic PLA2, except for
residues Cys61-Tyr68, is distinct from those
of eukaryotic secreted PLA2s that have already been
analyzed for the tertiary structure. As a striking difference,
eukaryotic PLA2s have 6-8 disulfide bonds, whereas the
bacterial enzyme has only two disulfide bonds. Over 150 primary structures of PLA2 have been already determined, and the
crystal (4-10) and NMR structures (11-13) of several
PLA2s, such as bovine and porcine pancreatic
PLA2s, snake and bee venom PLA2s, and human synovial fluid PLA2, have been solved.
Here, we show the crystal structure of the calcium-free S. violaceoruber PLA2, which was determined by using the
multiple isomorphous replacement methods and refined at a high
resolution of 1.4 Å. Furthermore, we determined the crystal structure
of the calcium-bound form by the molecular replacement method and refined it at a 1.6-Å resolution. This is the first report disclosing the x-ray crystal structure of prokaryotic PLA2. The x-ray
crystal structures of these two forms of the S. violaceoruber PLA2 were compared with those by the NMR
technique and also with the tertiary structures of eukaryotic
PLA2s. The x-ray crystal structure of the calcium-bound
S. violaceoruber PLA2 is concrete evidence that the catalytic hydrogen-bonding network is essentially flexible even in
the crystal structure. We believe that this observation will aid in
understanding the molecular mechanism for the catalysis of the secreted
PLA2s.
 |
EXPERIMENTAL PROCEDURES |
X-ray Crystallography of the Calcium-free S. violaceoruber
PLA2--
The S. violaceoruber PLA2
was purified to homogeneity and lyophilized as described previously
(41). Before crystallization, the lyophilized protein, dissolved
in a 10 mM Tris-HCl buffer, pH 8.0, containing 20 mM CaCl2, was adjusted to 20 mg/ml as a final concentration. Initial crystals were obtained by the vapor diffusion method at 297 K using the hanging drop technique (14). Drops
containing 5 µl of the protein solution and 5 µl of the reservoir
solution were equilibrated against the reservoir solution. The
reservoir solution contained 14% (w/v) polyethylene glycol 6000, 0.2 M Li2SO4, and 0.1 M
sodium cacodylate at pH 6.0. However, the crystals were heavily twinned
and dissolved at 292 K. Therefore, after the crystals were completely
dissolved, the drops were placed again at 297 K. The resulting single
crystals, which grew in 2 weeks to a size of 0.3 × 0.3 × 1.2 mm, were suitable for the diffraction analysis. These crystals
belong to the monoclinic space group P21 with
unit cell dimensions a = 29.4 Å, b = 57.8 Å, c = 31.7 Å, and
= 111.5° with one
molecule per asymmetric unit. After the structure determination, it was
revealed that no calcium ion bound to the protein.
All x-ray data were collected at room temperature. Initially, the
native data to 2.0-Å resolution was collected using an R-AXIS IIc
imaging plate with graphite monochromated CuK
radiation
from the rotating anode generator RU-200 run at 40 kV and 100 mA. Each oscillation frame was taken using a rotation of 3° for 20 min at a
crystal-to-detector distance of 80 mm. The diffraction intensities were
integrated and scaled using the Process program (15). A nearly complete
data set (94.6%) to a 2.0-Å resolution with high redundancy was
collected from a single crystal. This native data set was used for the
phase estimation at lower resolution and the preliminary refinement of
the constructed model.
Higher resolution data to 1.4 Å were later collected using the same
detector and the same x-ray source. The detector 2
angle was set to
35°, and the distance between its center and the crystal was set to
85 mm. Each oscillation frame was taken using a rotation of 1.5° for
15 min. In the highest resolution bin between 1.45 and 1.40 Å, this
data set was 37.4% complete with a signal-to-noise ratio
(I/
(I)) of 4.52. Details of the data
collection statistics are summarized in the top of Table
I.
The phase problem was solved to 2.7-Å resolution using the
PHASES program (16). Heavy atom derivatives were prepared by soaking
the crystal in the reservoir solution containing each heavy atom
reagent. Three derivatives (Pt, Au, and Rh) were used for the phasing
(middle of Table I). The position of the primary Pt site was easily
found in a difference Patterson map. The resulting single isomorphous
replacement phases were used to solve other sites of the derivatives.
The heavy atom parameters were refined, and a phase set with a figure
of merit of 0.74 was obtained. Anomalous scattering information of the
Pt derivative was utilized in this process, and anisotropic temperature
factors were used for each heavy atom.
A density modification with an extension to a 2.0-Å resolution was
performed by the solvent-flattening and histogram-matching method using
the SQUASH program (17). The molecular boundary was determined in the
electron density map applying a value of the solvent content of 20%,
which is smaller than the value calculated on the basis of one molecule
per asymmetric unit (33%). The resulting Fourier map enabled us to
trace the main chain easily, and the difference map calculated from the
native anomalous differences and the obtained phases confirmed the
location of two disulfide bonds and one sulfur atom of the Met residue.
An initial model was built into this modified map using the program
Xfit in the XtalView software package (18). This model gave an
R-factor of 39.8% for the reflections from 10.0- to 3.0-Å resolution. Refinement of the model was performed by a combination of
simulated annealing (19) and conventional restrained refinement methods
(20) using the X-PLOR program (21). A subset of 10% of the reflections
was used to monitor the free R-factor
(Rfree) (22). The refinement began with data
from 10.0- to 3.0-Å resolution, and the upper limit was raised to a
2.0-Å resolution. Each refinement cycle included the refinement of
positional parameters and individual isotropic temperature factors, the
revision of the model using the omit map, and the addition of the
solvent molecules. When the R-factor for the reflections
from 10.0- to 2.0-Å resolution fell below 20%, the native data was
changed to the 1.4-Å resolution data. Further rebuilding, the addition
of the solvent molecules, and the X-PLOR refinement yielded the current
model (bottom of Table I). The root mean square deviations from the
ideal geometry (23) are 0.008 Å in bond length, 1.9° in bond angle,
and 1.13° in improper angle.
X-ray Crystallography of the Calcium-bound S. violaceoruber
PLA2--
For crystallization, the protein solution was
prepared as described previously. Initial crystals were obtained by the
vapor diffusion at 297 K using the hanging drop method (14). Drops containing 5 µl of the protein solution and 5 µl of the reservoir solution were equilibrated against 1.0 ml of reservoir solution. The
typical reservoir solution contained 50-60% (v/v)
2-methyl-2,4-pentanediol and 0.1 M Tris-HCl at pH 8.5. However, the obtained crystals were heavily twinned. To obtain single
appropriate crystals, repeated seeding was performed using the crushed
crystals as seeds. Single crystals suitable for the diffraction
analysis (0.1 × 0.5 × 2.0 mm) grew in 1 week. They belong
to the space group P21 with unit cell dimensions
a = 38.3 Å, b = 54.3 Å,
c = 30.6 Å, and
= 90.2° with one molecule
per asymmetric unit. These preliminary crystallographic data have been
published (24).
X-ray analysis was performed at room temperature using an R-AXIS IIc
imaging plate with mirror monochromated CuK
radiation from the RU-300 rotating anode generator run at 40 kV and 100 mA. The
crystal was mounted with the crystallographic a* axis parallel to the crystal rotation axis. The crystal-to-detector distance
was set to 60 mm. Each frame of 2.5° crystal oscillation was taken
for 12 min. Diffraction spots in a rotation range of 142.5° were
recorded on a total of 57 frames. The diffraction intensities to a
1.6-Å resolution were integrated and scaled by the Process program
(15). In the highest resolution bin between 1.7- and 1.6-Å resolution,
this data set is 48.0% complete with a signal/noise ratio
(I/
(I)) of 2.41 and an
Rmerge of 28.3%. Details of the data collection
statistics are shown in Table I (top).
The crystal structure of the calcium-bound S. violaceoruber
PLA2 was solved by the molecular replacement procedure
using the programs in X-PLOR (21). The calcium-free form structure was used as search probe in a cross-rotation function against the data in a
resolution range of 10.0- to 4.0-Å. A single peak at Euler angles
1 = 183.3°,
2 = 72.5°, and
3 = 30.8° was 8.0
above the mean. A translational
search was carried out in two dimensions (x and
z). A top peak (x = 0.214, z = 0.425 in fractions of the unit cell) was observed at 7.2
above
the mean.
Refinement was first performed using the X-PLOR program (21). Atomic
coordinates, obtained by the molecular replacement method, were refined
against the data between 10.0 and 4.0 Å for 20 cycles with the entire
molecule as a rigid body, resulting in a crystallographic
R-factor of 35.8%. Atomic refinement of the model was
performed by using a combination of simulated annealing (19) and
conventional restrained refinement methods (20). A subset of 10% of
the reflections was used to monitor the Rfree (22). The refinement began with data from 10.0- to 3.0-Å resolution, and the upper limit was raised to a 1.6-Å resolution. Each refinement cycle included the refinement of positional parameters and individual isotropic temperature factors. After each refinement step,
2Fo
Fc and
Fo
Fc electron density maps were computed. The molecular modeling program Xfit in the XtalView program suit (18) was used on the Silicon Graphics workstations for
visualizing and rebuilding the model. Several cycles of the X-PLOR
refinement resulted in decreasing both the R-factor and Rfree to 20.1 and 26.5%, respectively, for the
reflections from 10.0 to 1.6-Å resolution with F > 2
. After the convergence on X-PLOR, further refinement was performed
using the SHELXL-97 program (25) against all of the reflections from
5.0- to 1.6-Å resolution with F > 0. Refinement
statistics are given at the bottom of Table I. The root mean square
deviations from the ideal geometry (23) are 0.008 Å in bond length,
1.9° in bond angle, and 1.13° in improper angle.
 |
RESULTS AND DISCUSSION |
Quality of the Electron Density Map and the Current Model--
As
shown in Fig. 1, a and
b, the final 2Fo
Fc
maps of the hydrophobic core region in the calcium-free form and the
calcium-binding site in the calcium-bound form structures exhibit very
high quality. Almost all aromatic amino acid residues as well as Pro
residues have a low density hole through the center of the rings, as
expected from the high resolution maps. Mean coordinate errors were
estimated by a Luzatti plot (26) to be 0.15 and 0.16 Å for the
calcium-free and calcium-bound PLA2s, respectively (data
not shown). Although all side chain atoms in the calcium-free form are
included in the final model, those of Gln7,
Arg28, Gln47, Phe53,
Lys103, and Trp112 have poorly defined electron
density. In the calcium-bound form, together with the side chain atoms
of these 6 residues, those of Asn29, Glu102,
and Lys119 were poorly defined. The C-terminal main- and
side-chain atoms in the calcium-bound form structure are flexible.
Mainly, the difference of distribution of the flexible residues between
calcium-free and calcium-bound forms seems to be caused by the
differences of their crystal-packing effects, as described below.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 1.
A portion of the final
2Fo Fc electron
density map. a, a map of the hydrophobic core region in
the calcium-free form structure at 1.4-Å resolution. The map
was contoured at 1.2 . b, a map of the calcium-binding
site in the calcium-bound form structure at 1.6-Å resolution. The map
was contoured at 1.0 .
|
|
In both cases, the Ramachandran plot (27, 28) shows that only
Leu44 is observed in the forbidden regions. The unusual
backbone conformation of Leu44 is stabilized by a hydrogen
bond formed between its backbone amide nitrogen and the
Thr42 hydroxyl oxygen.
Overall Structure--
On the geometry of class I/II
PLA2s, an anti-parallel
-sheet composed of two strands
is present together with
-helices accounting for 50% of the overall
structure (4-7, 9, 10). Class III bee venom PLA2 consists
of three kinds of long
-helices and a few
-strands (8). However,
the S. violaceoruber PLA2 only has an
-helical secondary structure consisting of five
-helices and two
helical segments (Fig. 2 and Fig.
3a). The current crystal structure model of the bacterial PLA2 is almost the same as
the NMR structure (41). To clarify the tertiary structure of
bacterial PLA2, we conveniently divided the structure into
the N- and C-terminal domains; the former domain consists of two
-helices (
1 and
2) and two
helical segments. The latter domain consists of three long
-helices
(
3,
4, and
5) and forms a
three-helix bundle. The three
-helices are tightly packed against
each other with an unusual slightly right-handed twist. The angles
among the three
-helices are 11°
(
3-
4), 18°
(
4-
5), and 19°
(
3-
5), respectively. Both domains are
linked to a long loop consisting of residues Glu37 to
Phe57. The
3-helix contains a homologous
segment consisting of the residues Cys61 to
Tyr68, and its orientation is almost anti-parallel to the
4-helix. The nearly anti-parallel helices are also
formed by
4- and
5-helices. These three
-helices are approximately perpendicular to the
2-helix.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Ribbon views of the calcium-free
(a) and calcium-bound (b) S. violaceoruber PLA2. This model was
created by the MOLSCRIPT program (39) and Raster3D (40). Helices or
helical segments are in red, and the turn region is in
blue. The yellow and green represent
the disulfide bonds and the calcium(II) ion, respectively. The current
structure has no -strands.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
a, amino acid sequence of the S. violaceoruber PLA2 and structurally homologous
segments of typical eukaryotic PLA2s. i),
S. violaceoruber; ii), N. naja atra
PLA2 (class I/II); iii), bee venom
PLA2 (class III). The catalytic and calcium-binding sites
are indicated in red and blue, respectively. The
secondary structures are defined by the MOLSCRIPT program (39).
b, stereoview of the superposition of the -carbon
backbone of the calcium-free S. violaceoruber
PLA2 (in red) on those of PLA2s that
are contained in N. naja atra (in blue) and bee
(in green) venoms. The structures of N. naja atra
and bee venom PLA2s are described in Refs. 7 and 8,
respectively.
|
|
The
-carbon backbone of the S. violaceoruber
PLA2 is superimposed on that of PLA2 from
Naja naja atra, the cobra snake (7), by the least squares
fit of the catalytic residues (Fig. 3b). The tertiary
structural similarity of backbone is limited to two long anti-parallel
-helices containing the residues composing the catalytic site. A
two-stranded
-sheet, commonly found in the class I/II
PLA2s, is absent in the bacterial PLA2.
Although the C-terminal
5-helix in the S. violaceoruber PLA2 corresponds to the N-terminal
-helix in the class I/II PLA2s, its orientation is
opposite. Similarly, the
-carbon backbone of the S. violaceoruber PLA2 is superimposed on that of
PLA2 from bee venom (8) (Fig. 3b). The
orientation of three long
-helices in the C-terminal domain of the
bacterial PLA2 is similar to that of PLA2 from
bee venom, whereas the overall structure of bacterial PLA2
is obviously different from that of the bee venom PLA2. The
overall structure of the S. violaceoruber PLA2
can be expressed as a shape in which the N-terminal domain of the
bacterial PLA2 is topologically added to a core region
consisting of three
-helices of the bee venom PLA2.
Despite the difference of the crystal lattice, the crystal structure of
the calcium-free form is identical with that of the calcium-bound form.
Fig. 4a shows the
superposition of the two forms using the main-chain atoms. The root
mean square positional differences between the two structures are 0.93 and 1.10 Å for main-chain atoms and for all protein atoms,
respectively. Marked structural deviations occur at the
Cys45
Ala48 residues in the long loop (Fig.
4b) and at the Lys119
Gly122
residues in the C-terminal region (Fig. 4c). The former
conformational change may be caused by binding of the calcium(II) ion
to the protein, and the latter may reflect the potential flexibility of
this region, as described below.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Stereoviews of conformational differences
between the calcium-free (dark gray) and
calcium-bound (light gray) forms of the
S. voolaceoruber PLA2. a,
superposition of the overall structure. Every 10th residue and the N-
and C-terminal residues are shown. Marked structural deviations occur
at residues Cys45-Ala48 in the long loop
(b) and the residues Lys119-Gly122
in the C-terminal region (c).
|
|
In the calcium-free S. violaceoruber PLA2
structure, although calcium(II) ion is contained in a buffer to grow
the crystal, the ion is absent in the model. This may be due to the
fact that the crystal is grown in the presence of sulfate ion at near
pH 6. Interestingly, even without calcium(II) ion, the current model maintains the conformational rigidity. The mean temperature factors are
11.0 Å2 for all protein atoms and 9.8 Å2 for
the main-chain atoms. On the other hand, the mean temperature factors
of the calcium-bound form structure increase to 30.1 Å2
for all protein atoms and 28.0 Å2 for the main-chain
atoms. Judging from the fact that VM (29) values
are extremely low (1.85 Å3 Da
1) for
calcium-free crystal and moderate (2.35 Å3
Da
1) for calcium-bound crystal, it can easily be
speculated that the differences of mean temperature factors are mainly
caused by the crystal packing effects. Despite the increase of its mean temperature factor, the calcium-bound form structure has a compact shape and enough rigidity when compared with other protein structures. Since eukaryotic PLA2s commonly have conformational
rigidity, it has been suggested that the rigidity is essential for the
expression of catalytic activity (30, 31). This suggestion holds true for the calcium-free S. violaceoruber PLA2
structure. However, the catalytic hydrogen-bonding network and the
substrate-binding site are flexible in the calcium-bound form of the
bacterial PLA2. Interestingly, recent studies of eukaryotic
PLA2s using the NMR method (11-13) showed the flexible
feature of the enzyme at a part of catalytic hydrogen-bonding network
and the substrate-binding site. The flexibility in the crystal
structure of the calcium-bound S. violaceoruber
PLA2 may be associated with these observations in the
solution structures of eukaryotic PLA2s.
The following point of the argument is the number of the
disulfide bonds. The conformational rigidity of eukaryotic
PLA2s is partially accomplished by a high content of
disulfide bonds (32). However, the S. violaceoruber
PLA2 has only two disulfide bonds. The salt bridges,
hydrogen bonds, and hydrophobic interactions seen in the structure of
the bacterial PLA2 may be useful to maintain the rigidity.
Catalytic Site and Surrounding Hydrogen-bonding Network--
The
overall structure of the S. violaceoruber PLA2
obviously differs from those of eukaryotic PLA2s. However,
the geometry of the catalytic site is conserved between eukaryotic and
prokaryotic cells (Fig. 5, a,
b, and c). The catalytic site of the prokaryotic PLA2 is stabilized by the formation of hydrogen-bonding
networks (Fig. 5, a and b). A marked structural
difference between the calcium-free and calcium-bound forms is the size
of the catalytic hydrogen-bonding network. In the calcium-free form,
the catalytic hydrogen-bonding network extends to the C-terminal region
(Fig. 5a). However, the C-terminal region in the
calcium-bound form does not participate in the catalytic
hydrogen-bonding network (Fig. 5b). We first describe the
catalytic site and the surrounding hydrogen-bonding network of the
bacterial PLA2 based on its calcium-free form
structure.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Stereoviews of the catalytic site and
surrounding hydrogen-bonding network. a and
b, the calcium-free and calcium-bound forms of the S. violaceoruver PLA2, respectively; c,
N. naja atra PLA2 (7). The hydrogen bonds are
shown by black broken lines. The
numbers in b and c show the distance
(Å) between calcium(II) ion and the His64 N 1 (the
His48 N 1 in N. naja atra).
|
|
The catalytic center of the bacterial PLA2 is
His64, which corresponds to His48 of the class
I/II PLA2s (Fig. 5c). An amino acid adjacent to His48 is Asp49, and its carboxylate functions
as ligands for binding to the calcium ion. In the bacterial
PLA2, the residue adjacent to His64 is also
Asp65, and its carboxylate is revealed to be the calcium
ligands. A residue, Asp85, found in the
4-helix of the bacterial PLA2, is a
counterpart of Asp99 of the class I/II PLA2s
(Fig. 5c), which forms a hydrogen bond with the
His64 N
2 (His48 in class I/II). The
Asp85 (Asp99 in class I/II) may play a role for
the neutralization of the positive charge of His64
(His48), formed during the catalytic reaction cleaving the
ester bond of the substrate.
A water molecule (Wat) or a hydroxyl ion, which forms a hydrogen bond
with the His48 N
1 in the class I/II PLA2s,
is inferred to attack nucleophilically the carbonyl carbon of the
substrate. Wat260, observed in the calcium-free form of the
bacterial PLA2 structure, seems to be a nucleophilic water
molecule. Thus, the geometry among Wat260,
His64, and Asp85, which is bridged in line by
the hydrogen bonds, is very similar to the catalytic triad of serine
proteases. This geometry is commonly observed not only in the class
I/II PLA2s but also in the class III enzyme. The existence
of the conserved catalytic geometry suggests that it may be essential
for the expression of the catalytic activity in all secreted
PLA2s.
The hydrogen-bonding network extends from the catalytic residues and
may help to stabilize the catalytic residues. The importance of the
catalytic hydrogen-bonding network and the resulting stable conformation of the catalytic site and its surroundings is pointed out
from the crystal structure analyses of other PLA2s (30, 31). Around the catalytic site of Class I/II PLA2s,
Tyr52, and Tyr73 are present, and their
phenolic hydroxyls interact with the Asp99 carboxyl oxygens
(Fig. 5c). The residues Tyr52 and
Tyr73 interact with a carboxyl oxygen, forming a hydrogen
bond to His48 and with the other carboxyl oxygen,
respectively. Residue Tyr68 in the bacterial
PLA2, corresponding to the class I/II Tyr52,
forms a hydrogen bond with Asp85. A stereochemical
analogous position of class I/II Tyr73 hydroxyl oxygen is
occupied by Wat263 linking to the C-terminal carboxylate
and the Lys119 amino group of the S. violaceoruber PLA2. In the crystal structures of class
I/II PLA2s, the catalytic hydrogen-bonding network extends to the surface loop through the N-terminal amino group. In the S. violaceoruber PLA2, the amino group of
Lys81 is linked by a salt bridge to the carboxyl oxygen of
Asp85. The positively charged Lsy81 amino group
bonds to the carboxylate of the C-terminal Gly122 by a salt
bridge and forms a hydrogen bond with the backbone carbonyl oxygen of
Val118, which has the negative electrostatic potential
generated by the
-helical dipole effect, at the C terminus of the
5-helix. In addition, the Asp85 carboxyl
oxygen links to the Lys119 amino group by the mediation of
one water molecule (Wat263) (Fig. 5a). These
interactions seem to be useful to stabilize the structure around the
catalytic site.
Second, we describe the conformational difference at the catalytic site
and its surroundings between calcium-free and calcium-bound form structures.
In the calcium-free form, a nucleophilic water molecule certainly
exists and makes a linear hydrogen bond with His64 N
1
(Fig. 5a). However, near the position of the nucleophilic water molecule observed in the calcium-free form structure, there are
no water molecules within hydrogen-bonding distance from the His64 N
1 in the calcium-bound form structure.
Wat201, which is one of the calcium ligands, exists at the
analogous position to the nucleophilic water, although it cannot make a hydrogen bond with His64 N
1. Instead,
Wat256, having a large temperature factor, forms a
nonlinear hydrogen bond with His64 N
1 (Fig.
5b). Probably, Wat256 nucleophilically attacks
the sn-2 carbonyl carbon of the substrate, and the resulting
oxyanion of the intermediate ligates to the calcium ion at the
analogous position of Wat201.
In the calcium-bound form structure, the Asp85 carboxyl
oxygen forms hydrogen bonds with the Tyr68 hydroxyl oxygen
and the Wat237 and salt bridges with the Lys81
amino group. The Lys81 amino group further forms hydrogen
bonds with the Tyr68 hydroxyl oxygen and Val118
carbonyl oxygen (Fig. 5b). The C-terminal Lys119
and Gly122 residues in the calcium-free form participate in
the hydrogen-bonding network (Fig. 5a). However, in the
calcium-bound form, the C-terminal region is highly flexible, having
large temperature factors, and does not interact with the catalytic
residues. Similarly, the NMR structure of the bacterial
PLA2 indicates that the C-terminal region is highly
flexible and makes no hydrogen bonds with the catalytic residues
regardless of the presence or absence of the calcium ion (41).
Therefore, the crystal structure of the calcium-bound form is thought
to be identical with the NMR structure. All x-ray analyses for other
eukaryotic PLA2s have shown conformational rigidity by the
catalytic hydrogen-bonding network. The structure of the calcium-bound
form of the bacterial PLA2 is the first evidence that the
catalytic hydrogen-bonding network of the secreted PLA2 is
essentially flexible even in the crystal structure.
In the solution structure of the porcine pancreatic PLA2, a
research group has observed that the N-terminal region and surface loop
are highly flexible. The formation of a hydrogen-bonding network
extended from the catalytic site is incomplete when compared with the crystal structure (11). However, the solution structure of the
porcine PLA2 complexed with a competitive inhibitor and micelles showed that the N-terminal region and surface loop take stable
conformations and form the complete hydrogen-bonding network, as seen
in the crystal structure (12). From these results, the research group
has concluded that the conformational change is caused by the existence
of the aggregated substrates and results in the formation of the
complete hydrogen-bonding network to stabilize the catalytic residues,
as observed in the crystal structure (13). Furthermore, they suggested
that this conformational change may explain the phenomenon that the
activity of PLA2 is much higher on aggregated substrates
than on monomolecularly dispersed phospholipids, so-called interfacial
activation (33).
The crystal structure of the bacterial calcium-free PLA2 is
significantly different at the C-terminal region with a solution structure (41). The crystal structure expects the C-terminal region to participate in the catalytic hydrogen-bonding network. These
observations for the S. violaceoruber PLA2 are
quite similar to the results of porcine pancreatic PLA2
(11-13). Therefore, we think that flexibility in the C-terminal region
of the S. violaceoruber PLA2 is caused by the
lack of aggregated substrates, and that, in the case of the
calcium-free form, the obtained crystal structure may be derived from
the preferential crystallization of one protein conformer resembling
the interfacial activated enzyme. However, in the calcium-bound form
structure, the C-terminal region is highly flexible and does not
interact with catalytic residues, as seen in its solution structure
(41). Why does preferential crystallization not occur in the
case of the calcium-bound form? The difference of the crystal packing
effects between two crystal structures of calcium-free and
calcium-bound forms may be a primary reason. In the calcium-free form
structure, the C-terminal region has close interactions to the
symmetry-related molecules, whereas, in the calcium-bound form, it
protrudes to the bulk solvent region with no interactions to the
symmetry-related molecules. Another possible explanation could be found
in the difference of the crystallization pH. Atomic resolution analysis
(our unpublished data)2 of
the calcium-free form structure revealed that a catalytic residue
His64 exhibits a positive charge in the crystal grown at pH
6.0. This protonation state is analogous to the intermediate state
immediately after the nucleophilic water attacks the
sn-2 carbonyl carbon of the substrate. However, in the
calcium-bound form crystals, which were grown under pH 8.5 conditions,
the His64 residue must have no charge. It is reasonable
that, when the charge condition of the catalytic residues resembles an
intermediate state, a catalytic hydrogen-bonding network forms more
easily. Therefore, the charge effect appears to cause the
conformational difference at the C-terminal region between the
calcium-free and calcium-bound form crystal structures.
Calcium-binding Site--
The S. violaceoruber
PLA2 possesses no calcium-binding sequence useful for the
formation of a calcium-binding loop,
X-Cys-Gly-X-Cys, which was found in the primary
structure of eukaryotic PLA2s (Fig. 3a). We
could not even find any structure corresponding to the calcium-binding
loop. The calcium-binding affinity of the bacterial PLA2 is
1 order of magnitude lower than those of eukaryotic
PLA2s, suggesting that the lower affinity may be due to the
absence of a calcium-binding loop. This also suggests that the
bacterial PLA2 must have a calcium-binding mechanism
different from that of eukaryotic PLA2s.
As shown in Fig. 1b, calcium(II) ion was clearly defined in
the electron density. Judging from the relatively lower temperature factor of the calcium ion, it is thought that calcium ion is tightly bound to the protein. Calcium(II) ion is heptacoordinated by a pentagonal bipyramidal cage of oxygens (Fig.
6b) as well as other extracellular PLA2s (6-9). However, its binding manner is
quite different from that of other PLA2s. In other
PLA2s, calcium ligands are two carboxyl oxygens of an
invariant Asp residue, three backbone carbonyl oxygens of the highly
conserved "calcium-binding loop," and two water molecules (6-9).
Fig. 6c shows the calcium-binding site of N. naja
atra PLA2 (7) as an example. It is noted that two
axial ligands are the Tyr28 carbonyl oxygen and one of two
bound waters (Wat202). On the other hand, in the S. violaceoruber PLA2, the structural counterpart of the
"calcium-binding loop" does not exist. As shown in Fig.
6b, the calcium-bound form structure reveals that calcium ligands are both carboxyl oxygens of Asp65, one carboxyl
oxygen of Asp43, a carbonyl oxygen of Leu44,
and three water molecules, and that the axial ligands are both Asp43 carboxyl oxygen and one of three bound waters
(Wat201).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 6.
Stereoviews of the calcium-binding site.
a and b, the calcium-free and calcium-bound forms
of the S. violaceoruver PLA2, respectively;
c, N. naja atra PLA2 (7). A
green ball represents the calcium(II) ion. The
hydrogen bonds and coordination bonds to the calcium (II) ion are shown
by black broken lines.
|
|
The residue Asp65 is adjacent to the catalytic residue
His64. The His-Asp primary sequence is conserved among all
of the extracellular PLA2s, and the Asp residue at this
position contributes two carboxyl oxygens to the calcium ligation.
Therefore, it was easily speculated from the amino acid sequence that
Asp65 of the S. violaceoruber PLA2
contributes to the calcium ligation. The current model of the
calcium-bound form shows clearly that two carboxyl oxygens of
Asp65 function as the calcium ligands. In the current
calcium-bound form structure, the side chain of Asp65 is
stabilized by two hydrogen bonds, as in the calcium-free form structure. One of two proton donors is the hydroxyl of
Thr42, and the other is the backbone amide of
Asp43. Probably due to these hydrogen bonds, the torsion
angle of the Asp65 side chain of the S. violaceoruber PLA2 is considerably different from that
of the corresponding Asp residue of other PLA2s.
Similarly, because of the positional relation to Asp65, it
was easily speculated even from the calcium-free form structure that the Leu44 carbonyl oxygen is one of the calcium ligands.
The current calcium-bound form structure shows that this idea is sure.
However, the Leu44 carbonyl oxygen of the S. violaceoruber PLA2 is an equatorial ligand to the
calcium(II) ion, whereas the carbonyl oxygen of the corresponding
residue of other PLA2s (Tyr28 for N. naja
atra PLA2 (7)) is an axial ligand.
An Asp43 carboxylate makes salt links to the
Arg69 guanidino group in the calcium-free form structure
(Fig. 6a). However, the Asp43 carboxylate does
not make such salt bridges in the calcium-bound form structure.
Moreover, the rearrangement of the Asp43 side chain occurs
by the rotation around the bond between C
and C
atoms, and one of
the Asp43 carboxyl oxygens participates in the calcium
binding (Fig. 6b). On the other hand, we tried to construct
a model for the phosphatidylcholine, major substrate for this enzyme,
into the current protein structure by manual fitting, based on
the information of the crystal structures of other PLA2s in
a complex with the substrate analogue (6, 8, 9). The resulting model
strongly suggests that the sn-3 choline group of the
substrate may be packed with the methylene unit of Arg69,
whose guanidino group salt-links to Asp43 carboxylate in
the calcium-free form structure, and with that of Lys72 by
hydrophobic interaction. Therefore, the conformational change of the
Asp43 side chain is very attractive, and it is suggested
that there may be a correlation between calcium binding and substrate
recognition (i.e. calcium binding may cause a conformational
change suitable for substrate recognition and vice
versa.
As described above, three water molecules bind to the calcium(II) ion.
These waters are buried inside the protein, and two out of three form
hydrogen bonds to the protein atoms. Wat201 forms a
hydrogen bond with the Cys61 carbonyl oxygen, and
Wat202 forms a hydrogen bond with the Thr46
carbonyl oxygen. In the calcium-free form, the
Cys45-Ala48 residues form a type I
-turn,
and the Thr46 carbonyl oxygen protrudes toward the solvent
region (Fig. 6a). However, in the calcium-bound form, the
Cys45-Ala48 residues form a type II
-turn,
and the Thr46 carbonyl oxygen protrudes toward the protein
interior (Fig. 6b). This backbone-conformational change
enables the formation of a hydrogen bond between the Thr46
carbonyl oxygen and the Wat202 molecule. As a result,
Wat202 is considerably stabilized and has a relatively
lower temperature factor (27.1 Å2). Since NMR structure
analysis indicated that a long loop region including residues
Cys45-Ala48 is highly flexible in the absence
of the calcium(II) ion (41), it is thought that a calcium-free
form structure may be derived from the preferential crystallization of
one protein conformer, in which residues
Cys45-Ala48 form a type I
-turn. However,
judging from the appropriate conformation of the calcium-binding site,
the current calcium-bound crystal structure should be correctly
determined and also reflect the structure in solution.
The calcium(II) ion is essential for both substrate binding and
catalysis. The x-ray analyses of other PLA2s in a complex with the substrate analogue (6, 8, 9) revealed that two waters bound to
calcium(II) ion are replaced by the pro-S nonbridging oxygen
of the sn-3 phosphate of the substrate and the
sn-2 oxyanion of the putative tetrahedral intermediate. When
comparing the S. violaceoruber PLA2 with the
complexed form of other PLA2s, the position of
Wat201 corresponds to the sn-2 oxyanion of the
substrate analogue, and the position of Wat203 corresponds
to the sn-3 phosphate oxygen. Because of the positional relation of the bound waters, we anticipate that Wat201 is
replaced by the oxyanion of the putative tetrahedral intermediate and
that Wat203 is replaced by the sn-3 phosphate
oxygen of the substrate during catalysis of the S. violaceoruber PLA2.
Substrate-binding Site--
As mentioned above, we believe that
the calcium-free form is more similar to the activated structure at the
interface than the calcium-bound form. Therefore, we discuss the
substrate-binding site of the bacterial PLA2 based on its
calcium-free form structure.
In class I/II PLA2s, a hydrophobic channel is formed by the
apolar side chains of the invariant or highly conserved residues (6,
9). This channel accommodates the aliphatic chains of the
sn-1 and sn-2 substituents of the substrate and
plays a role to keep the polar residues participating in the catalytic
hydrogen-bonding network from the solvent region. Although only one
crystal structure complexed with a substrate or an inhibitor can
provide an atomic model for the protein-substrate interactions, the
current structure allows us to identify the hydrophobic channel. The
hydrophobic channel of the S. violaceoruber PLA2
consists of Cys45 and Pro49 in the long loop;
Cys61 in the
3-helix; Phe88 and
Met92 in the
4-helix; Tyr114,
Ala117, and Val118 in the
5-helix; and Ile120 and Phe121
(Fig. 7). In these residues, a disulfide
bond is formed between Cys45 and Cys61. It is
very interesting that residues Ile120 and
Phe121, which are speculated to form a hydrophobic channel,
have a stable conformation in the calcium-free form but not in the
calcium-bound form. This may imply that the conformational change by
interfacial activation results in the stabilization of the
substrate-binding site as well as the catalytic hydrogen-bonding
network.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 7.
Stereoview of the proposed hydrophobic
channel of the S. violaceoruber PLA2.
The conserved catalytic residues His64 and
Asp85 and the invariant residue Tyr68 are shown
in red. They are connected through a hydrogen bond to the
nucleophilic water molecule (also in red). The side chains
of the residues forming the proposed hydrophobic channel are shown in
orange. The side chains of Arg69 and
Lys72 forming the putative choline-receiving pocket are
shown in purple. This model is based on the calcium-free
form structure, and the calcium(II) ion (green) is put in
position estimated from the calcium-bound form.
|
|
In the class I bovine pancreatic PLA2, a choline group
esterified to the sn-3 phosphate is held in a region
designated a choline-receiving pocket, consisting of the methylene
units of the side chains of Lys53 and Lys56
(34, 35). The corresponding positions on the S. violaceoruber PLA2 are Arg69 and
Lys72, which also have a long methylene unit. The
Arg69 side chain makes a hydrogen bond to the
Ser41 hydroxyl oxygen and a salt bridge to a calcium
ligand, the Asp43 carboxylate oxygen, in the calcium-free
form structure, and the latter salt bridge disappears in the
calcium-bound form, suggesting that a correlated mechanism for the
calcium binding and the substrate recognition may be present. The
presence of these residues corresponding to the choline-receiving
pocket may be a possible reason for the substrate preference to the
phosphatidylcholine of this enzyme.
Interfacial catalysis of PLA2 involves interfacial binding
prior to the catalytic step. PLA2s have an interfacial
binding site, which surrounds the opening of the hydrophobic channel, to bind the aggregated substrate. The positively charged residues at
the interfacial binding site mainly contribute to the binding to the
anionic phospholipids (36), whereas the aromatic residues mainly
contribute to the binding to the zwitterionic ones (37). The S. violaceoruber PLA2 prefers zwitterionic phospholipids, although the molecular surface on the bacterial enzyme structure is
mainly occupied with hydrophilic residues. In this case, a few aromatic
residues, such as Trp112 and Phe53, found in
the putative interfacial binding site, are thought to play a role as a
linker for binding to the interface of zwitterionic phospholipids.
Conformational Rigidity--
The enzyme activity of the S. violaceoruber PLA2 is not lost under incubation at
50 °C for 10 min (41). This thermostable PLA2 has
only two disulfide bonds, but its structure is highly rigid, like that
of eukaryotic PLA2s having several difulfide bonds. The
lack of some disulfide bonds may be supplemented with the polar and
apolar interactions. Since any interaction between residues adjacent on
the primary structure is not useful in discussing the
conformational rigidity of the bacterial PLA2, the hydrogen bonds and salt bridges forming between residues separated
from each other on the primary sequence are listed in Table
II.
The hydrophobic interactions predominantly contribute to the structural
rigidity of the N-terminal domain. The aromatic and aliphatic side
chains of this domain and certain aromatic side chains in the
C-terminal domain (Phe66 and Tyr71 in the
3-helix) are tightly packed by the hydrophobic
interaction. This hydrophobic core lies near the catalytic
hydrogen-bonding network and prevents the solvent molecules from
invading the catalytic site or the hydrophobic channel. In addition to
the apolar interactions, some polar interactions are present between
the N- and C-terminal domains. The carboxyl end of the
1
helix, having a negative electrostatic potential by
the helix dipole effect, is stabilized by the positively charged
residues, such as Arg63 and Arg83, in the
C-terminal domain.
A disulfide bond between Cys45 in the long loop and
Cys61 in the
3-helix of the bacterial
PLA2 contributes to stabilize the long loop that has no
secondary structures. Interestingly, this disulfide bond is present
also in the eukaryotic PLA2s. Perhaps this conserved bond might be helpful for the linkage of the catalytic site to the
calcium-binding site. In addition, the current models have several
polar interactions, such as five or six hydrogen bonds, between the
long loop and the
3-helix (Table II).
In eukaryotic PLA2s, the anti-parallel
-helices
containing catalytic residues are held by two disulfide bonds, which
are conserved at both ends. However, the S. violaceoruber
PLA2 does not have the disulfide-bond between the
3- and
4-helices. In general, the
anti-parallel helices are known to be structurally unstable in terms of
energy (38). This disadvantage may be overcome by a polar interaction
between the Arg63 guanidino group and the Asp91
carboxylate at the center of the
-helices and by the presence of the
N-terminal domain lying on both 
helices.
Another pair of anti-parallel
-helices, the
4- and
5
helices, has a disulfide bond between
Cys96 and Cys107 at one end. Several
hydrophobic side chains, derived from these
-helices and the long
loop, are observed around the disulfide bond. These side chains, packed
by the hydrophobic interaction, are useful to keep the conformational
rigidity. As mentioned above, at the other end of these anti-parallel
-helices, there is a hydrogen bond between the Lys81
amino group and Val118 carbonyl, which may be useful to
stabilize the conformation around the catalytic site. A salt bridge
between the Lys81 amino group and Gly122
terminal carboxylate exists only in the calcium-free form and not in
the calcium-bound form.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. A. Yamano (Institute
of X-ray Research, Rigaku Co., Japan) for valuable discussion about
x-ray protein crystallographic analysis. We thank Dr. T. Koike and K. Ohtani (Institute of Pharmaceutical Sciences, Faculty of Medicine,
Hiroshima University) for valuable discussion about the catalytic
mechanism of the bacterial PLA2.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1FAZ and 1KP4) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed. Tel.:
81-82-257-5280; Fax: 81-82-257-5284; E-mail:
sugi@hiroshima-u.ac.jp.
Published, JBC Papers in Press, March 15, 2002, DOI 10.1074/jbc.M200263200
2
Y. Matoba and M. Sugiyama, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
PLA2, phospholipase A2;
Wat, water molecule.
 |
REFERENCES |
| 1.
|
Dennis, E. A.
(1994)
J. Biol. Chem.
269,
13057-13060[Free Full Text]
|
| 2.
|
Six, D. A.,
and Dennis, E. A.
(2000)
Biochim. Biophys. Acta
1488,
1-19[Medline]
[Order article via Infotrieve]
|
| 3.
|
Gelb, M. H.,
Valentin, E.,
Ghomashchi, F.,
Lazdunski, M.,
and Lambeau, G.
(2000)
J. Biol. Chem.
275,
39823-39826[Abstract/Free Full Text]
|
| 4.
|
Dijkstra, B. W.,
Kalk, K. H.,
Hol, W. G. J.,
and Drenth, J.
(1981)
J. Mol. Biol.
147,
97-123[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Brunie, S.,
Bolin, J.,
Gewirth, D.,
and Sigler, P. B.
(1985)
J. Biol. Chem.
260,
9742-9749[Abstract/Free Full Text]
|
| 6.
|
Thunnissen, M. M. G. M., AB, E.,
Kalk, K. H.,
Drenth, J.,
Dijkstra, B. W.,
Kuipers, O. P.,
Dijkman, R.,
de Haas, G. H.,
and Verheij, H. M.
(1990)
Nature
374,
689-691
|
| 7.
|
Scott, D. L.,
White, S. P.,
Otwinowski, Z.,
Yuan, K.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1541-1546[Abstract/Free Full Text]
|
| 8.
|
Scott, D. L.,
Otwinowski, Z.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1563-1566[Abstract/Free Full Text]
|
| 9.
|
White, S. P.,
Scott, D. L.,
Otwinowski, Z.,
Gelb, M. H.,
and Sigler, P. B.
(1990)
Science
250,
1560-1563[Abstract/Free Full Text]
|
| 10.
|
Wery, J. P.,
Schevitz, R. W.,
Clawson, D. K.,
Bobbitt, J. L.,
Dow, E. R.,
Gamboa, G.,
Goodson, T. Jr.,
Hermann, R. B.,
Kramer, R. M.,
McClure, D. B.,
Mihelich, E. D.,
Putnam, J. E.,
Sharp, J. D.,
Stark, D. H.,
Teater, C.,
Warrick, M. W.,
and Jones, N. D.
(1991)
Nature
352,
79-82[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
van den Berg, B.,
Tessari, M.,
de Haas, G. H.,
Verheij, H. M.,
Boelens, R.,
and Kaptein, R.
(1995)
EMBO J.
14,
4123-4131[Medline]
[Order article via Infotrieve]
|
| 12.
|
van den Berg, B.,
Tessari, M.,
Boelens, R.,
Dijkman, R.,
Kaptein, R.,
de Haas, G. H.,
and Verheij, H. M.
(1995)
J. Biomol. NMR
5,
110-121[Medline]
[Order article via Infotrieve]
|
| 13.
|
van den Berg, B.,
Tessari, M.,
Boelens, R.,
Dijkman, R.,
de Haas, G. H.,
Kaptein, R.,
and Verheij, H. M.
(1995)
Nat. Struct. Biol.
2,
402-406[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
McPherson, A.
(1982)
The Preparation and Analysis of Protein Crystals
, 1st Ed.
, pp. 96-97, John Wiley & Sons Inc., New York
|
| 15.
|
Higashi, T.
(1990)
J. Appl. Crystallogr.
23,
253-257
|
| 16.
|
Furey, W.,
and Swaminathan, S.
(1990)
Methods Enzymol.
276,
472-494
|
| 17.
|
Zhang, K. Y. J.,
and Main, P.
(1990)
Acta Crystallogr. A
46,
377-381[CrossRef]
|
| 18.
|
McRee, D. E.
(1992)
J. Mol. Graphics
10,
44-46[CrossRef]
|
| 19.
|
Brünger, A. T.,
Kuriyan, J.,
and Karplus, M.
(1987)
Science
235,
458-460[Abstract/Free Full Text]
|
| 20.
|
Konnert, J. H.,
and Hendrickson, W. A.
(1980)
Acta Crystallogr. Sect. A
36,
344-350[CrossRef]
|
| 21.
|
Brünger, A. T.
(1993)
X-PLOR Version 3.1 Manual
, Yale University Press, New Haven, CT
|
| 22.
|
Brünger, A. T.
(1992)
Nature
355,
472-475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Engh, R. A.,
and Huber, R.
(1991)
Acta Crystallogr. Sect. A
47,
392-400[CrossRef]
|
| 24.
|
Matoba, Y.,
Kumagai, T.,
and Sugiyama, M.
(2000)
J. Inorg. Biochem.
82,
221-223[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Sheldrick, G. M.,
and Schneider, T. R.
(1997)
Methods Enzymol.
277,
319-343[Medline]
[Order article via Infotrieve]
|
| 26.
|
Luzzati, V.
(1952)
Acta Crystallogr.
5,
802-810[CrossRef]
|
| 27.
|
Ramachandran, G. N.,
Ramakrishnan, C.,
and Sasisekharan, V.
(1963)
J. Mol. Biol.
7,
95-99[Medline]
[Order article via Infotrieve]
|
| 28.
|
Kleywegt, G. J.,
and Jones, T. A.
(1996)
Structure
4,
1395-1400[Medline]
[Order article via Infotrieve]
|
| 29.
|
Matthews, B. W.
(1968)
J. Mol. Biol.
33,
491-497[Medline]
[Order article via Infotrieve]
|
| 30.
|
Dijkstra, B. W.,
van Nes, G. J. H.,
Kalk, K. H.,
Brandenburg, N. P.,
Hol, W. G. J.,
and Drenth, J.
(1982)
Acta Crystallogr. Sect. B
38,
793-799
|
| 31.
|
Dijkstra, B. W.,
Kalk, K. H.,
Drenth, J.,
de Haas, G. H.,
Egmond, M. R.,
and Slotboom, A. J.
(1984)
Biochemistry
23,
2759-2766[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Zhu, H.,
Dupureur, C. M.,
Zhang, X.,
and Tsai, M.-D.
(1995)
Biochemistry
34,
15307-15314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Gelb, M. H.,
Jain, M. K.,
Hanel, A. M.,
and Berg, O. G.
(1995)
Annu. Rev. Biochem.
64,
653-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Noel, J. P.,
Bingman, C.,
Deng, T.,
Dupureur, C. M.,
Hamilton, K. J.,
Jiang, R. T.,
Kwak, J.-G.,
Sekharudu, C.,
Sundaralingam, M.,
and Tsai, M.-D.
(1991)
Biochemistry
30,
11801-11811[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Tomoo, K.,
Ohishi, H.,
Ishida, T.,
Inoue, M.,
Ikeda, K.,
Sumiya, S.,
and Kitamura, K.
(1994)
Proteins Struct. Funct. Genet.
19,
330-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Snitko, Y.,
Han, S. K.,
Lee, B. I.,
and chp, W.
(1999)
Biochemstry
38,
7803-7810[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Sumandea, M.,
Das, S.,
Sumandea, C.,
and Cho, W.
(1999)
Biochemistry
38,
16290-16297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Chothia, C.,
Levitt, S.,
and Richardson, D.
(1981)
J. Mol. Biol.
145,
215-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 40.
|
Merritt, E. A.,
and Murphy, M. E. P.
(1994)
Acta Crystallogr. Sect. D
50,
869-873[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Sugiyama, M.,
Ohtani, K.,
Izuhara, M.,
Koike, T.,
Suzuki, K.,
Imamura, S.,
and Misaki, H.
(2002)
J. Biol. Chem.
277,
20051-20058[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore